Octagon Capital Advisors LP 13D and 13G filings for Taysha Gene Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:46 pm Sale | 2025-09-30 | 13G | Taysha Gene Therapies, Inc. TSHA | Octagon Capital Advisors LP | 9,067,500 3.300% | -1,382,500 (-13.23%) | Filing |
| 2025-02-05 6:05 pm Purchase | 2024-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | Octagon Capital Advisors LP | 10,450,000 5.100% | 10,450,000 (New Position) | Filing |